Nanomedicine - Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer
Can't see this email? View it online
   
  Nanomedicine  
  The latest nanomedicine news from News Medical  
 

#ALT# Characterization of nano-pharmaceuticals with FFF-MALS-DLS

AF4-MALS-DLS provide a pathway to meeting the requirements of regulatory agencies for enhanced characterization of liposomal drug formulations and other nanoparticle drug delivery systems

Learn More
 
   Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancerCombining nanotechnology with immunotherapy to fight deadly metastatic breast cancer
 
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
 
   The Use of Nanosensors to Restore Retinal VisionThe Use of Nanosensors to Restore Retinal Vision
 
Researchers from Tübingen University, Germany have determined a method to sensitize the retina to light by selectively targeting failed photoreceptors.
 
 New nanomedicine is efficient and less aggressive than conventional prostate cancer therapy
 
New nanomedicine is efficient and less aggressive than conventional prostate cancer therapyProstate cancer is the most common type of cancer among European men; its incidence surpasses 100 cases per 100,000 people.
 
 
 New study shows efficacy of carbon nanotube implants to restore motor functions
 
New study shows efficacy of carbon nanotube implants to restore motor functionsA new study conducted by SISSA and the University of Trieste shows the efficacy of carbon nanotube implants to restore motor functions and paves the way for a new therapeutic approach for spinal cord injuries.
 
 
 Study demonstrates new method to synthesize gold nanoparticles in cancer cells
 
Study demonstrates new method to synthesize gold nanoparticles in cancer cellsDipanjan Pan, professor of chemical, biochemical, and environmental engineering at UMBC, and collaborators published a seminal study in Nature Communications that demonstrates for the first time a method of biosynthesizing plasmonic gold nanoparticles within cancer cells, without the need for conventional bench-top lab methods.